Sector: Pharmaceuticals & Biotechnology

Small Cap

Indoco Remedies Share Price

Q: What is the current share price of Indoco Remedies Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Indoco Remedies Ltd. is ₹ 195.7 on the NSE and ₹ 195.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Indoco Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Indoco Remedies Ltd. is approximately ₹ 1806.8 Cr.

Q: What are the PE and PB ratios for Indoco Remedies Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Indoco Remedies Ltd. is -19, and the Price-to-Book (PB) ratio is 1.9.

Q: What is the 52-Week High and Low for Indoco Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Indoco Remedies Ltd. shares was ₹ 349.8, and the lowest price was ₹ 162.19.

Q: What is the current dividend yield for Indoco Remedies Ltd.?

As of 6 June 2025, the dividend yield for Indoco Remedies Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Q: Who are the major shareholders of Indoco Remedies Ltd.?

Significant shareholdings in Indoco Remedies Ltd. typically include entities such as: Promoter Public Mutual Funds FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Indoco Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Indoco Remedies Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Q: What is the latest dividend information for Indoco Remedies Ltd.?

Indoco Remedies Ltd. last declared a FINAL dividend of ₹ 0.2 per share for the financial period ending 2025. The record date was set as 2025-09-04, and the payment was/is scheduled around 2025-09-04. For the most current dividend announcements, refer to official company filings.

Q: What is the shareholding pattern for Indoco Remedies Ltd.?

As per the filings for the quarter ending Mar 2026, the approximate shareholding pattern for Indoco Remedies Ltd. is: Promoters: 58.9% Domestic Institutional Investors (DII): 18.2% Foreign Institutional Investors (FII): 0.9% Others (including Public): 0.1%

Indoco Remedies Ltd.

₹195.70

-3.38(-1.70%)

Invest in INDOCO with up to 2.50x margin.

Trade with MTF

25th May 2026 | 3:28 PM

NSE : INDOCO

Open Free Demat Account

Indoco Remedies Performance

Price Movement

₹195.70

₹194.99

₹202.92

↘ Today's Low↗ Today's High

1 Year Performance

₹195.70

₹162.19

₹349.80

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹202.92

Low₹194.99

Open at₹202.09

Prev Close₹199.08

Volumes84.99 K

Avg Price₹197.82

Lower Circuit₹159.27

Upper Circuit₹238.89

Historical Performance

3M High₹270.00

3M Low₹162.19

1 Yr High₹349.80

1 Yr Low₹162.19

3 Yr High₹415.00

3 Yr Low₹162.19

5 Yr High₹530.25

5 Yr Low₹162.19

Indoco Remedies Fundamentals

Market Cap

Above industry Median

1,806.80 Cr.

PE Ratio (TTM)

Negative PE TTM

-19

Dividend Yield

Low in industry

0.10

Net Profit TTM

29% decr over last year

-95.15

Net Profit Growth

29% decr over last year

-95.15

PEG Ratio

Above industry Median

0.70

ROE

40% decr over last year

-10.13

Operating Revenue TTM

1,843.53

Operating Revenue Growth

10.7% incr over last year

Book Value

Below industry Median

1.90

MFI

MFI is mid-range

69.42

RSI

RSI is mid-range

40.17

EPS (TTM)

-10.70

Debt to Equity

1.10

Face Value

Operating Profit Margin Qtr.

7.67

Operating Profit Qtr.

49.71

Net Profit Qtr.

-21.64

Operating Revenue Qtr.

475.61

PB Ratio

1.90

Indoco Remedies Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	449.13	400.51	442.12	392.53	347.25
Operating Expense	386.10	374.61	388.73	377.70	343.79
Operating Profit	63.03	25.90	53.39	14.83	3.46
Depreciation	26.71	27.36	27.63	25.20	24.88
Interest	22.73	20.15	22.01	23.61	15.98
Tax	0.27	-0.45	-5.29	-0.34	-4.66
Net Profit	27.35	-20	15.05	-28.06	-26.24

Indoco Remedies Technicals

Indoco Remedies Ltd. EMA & SMA

₹195.70

-3.38 (-1.70%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹208

Day EMA10 ₹212.9

Day EMA12 ₹213.8

Day EMA20 ₹214.2

Day EMA26 ₹213.4

Day EMA50 ₹211.3

Day EMA100 ₹217

Day EMA200 ₹234.3

Indoco Remedies Support and Resistance

Resistance

First Resistance₹203.95

Second Resistance₹208.82

Third Resistance₹212.14

Support

First Support₹195.76

Second Support₹192.44

Third Support₹187.57

Technical Indicators

Day RSI40.17

Day MFI69.42

Day ADX28.63

Day Commodity Channel Index-133.80

William-97.57

Day MACD0.36

Day MACD Signal Line3.67

Day ATR10.26

Day ROC125-25.73

Day ROC21-7.05

Indoco Remedies Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	58.8	58.9	58.9	58.9	58.9	58.9
FII	1.2	1.2	1.2	1.2	1.1	0.9
DII	19	18.8	19	18.2	18.1	18.2
Public	21	21	20.8	21.6	21.8	21.9

Indoco Remedies Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	61.25 K	93.48 K	65.52%
Week	45.38 K	70.28 K	64.57%
1 Month	51.76 K	1.42 L	36.39%
6 Month	30.62 K	68.79 K	44.51%

Indoco Remedies SWOT Analysis

Strengths8

Weakness15

Opportunity0

Threats2

Rising Net Cash Flow and Cash from Operating activity

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

PEG lower than Industry PEG

Small Cap Stars

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Volume Shockers

Indoco Remedies Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
04 Sep, 2025	0.2	FINAL	04 Sep, 2025	Equity Share
19 Sep, 2024	1.5	FINAL		Equity Share
18 Sep, 2023	2.25	FINAL		Equity Share
14 Sep, 2022	0.75	SPECIAL		Equity Share
14 Sep, 2022	1.5	FINAL		Equity Share
17 Sep, 2021	1.5	FINAL		Equity Share
18 Sep, 2020	0.3	FINAL		Equity Share
22 Aug, 2019	0.3	FINAL		Equity Share
31 Aug, 2018	1	FINAL		Equity Share
31 Jul, 2017	1.6	FINAL		Equity Share

Indoco Remedies Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Innova Captab Ltd.
Price (₹)	₹492.90	₹6.40	₹131.01	₹13.79	₹559.75	₹852.80
% Change	1.27%	-2.14%	0.71%	-0.86%	0.46%	0.53%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	-	₹502.55	₹1,630.02
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	-	₹57.92	₹140.92
PE TTM	-	-1.50	34.50	-	28.10	34.70
1 Year Return	24.95	544	4.98	51.43	-21.64	-3.98
ROCE	3.56	-5.63	-	-	23.87	15.27

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 78.00

+1.46%

SIGACHI

Sigachi Industries Ltd.

₹ 20.34

-0.05%

WINDLAS

Windlas Biotech Ltd.

₹ 784.40

-0.70%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

-1.69%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 556.00

+1.44%

ZIMLAB

Zim Laboratories Ltd.

₹ 99.45

-0.71%

MEDICO

Medico Remedies Ltd.

₹ 48.93

+2.28%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 198.45

+1.58%

LASA

Lasa Supergenerics Ltd.

₹ 8.07

+1.00%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 376.50

+0.36%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 302.20

-1.10%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.06

BROOKS

Brooks Laboratories Ltd.

₹ 56.41

+4.99%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2243.00

-2.22%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 135.50

+0.35%

ALPA

Alpa Laboratories Ltd.

₹ 67.85

-1.89%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 371.45

-2.62%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.03

-0.25%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 29.01

-1.36%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 133.00

+0.92%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 722.00

-1.65%

PANACEABIO

Panacea Biotec Ltd.

₹ 419.90

+0.32%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 268.35

-0.45%

FAQ's on INDOCO

What is the current share price of Indoco Remedies Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Indoco Remedies Ltd. is ₹ 195.7 on the NSE and ₹ 195.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Indoco Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Indoco Remedies Ltd. is approximately ₹ 1806.8 Cr.

What are the PE and PB ratios for Indoco Remedies Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Indoco Remedies Ltd. is -19, and the Price-to-Book (PB) ratio is 1.9.

What is the 52-Week High and Low for Indoco Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Indoco Remedies Ltd. shares was ₹ 349.8, and the lowest price was ₹ 162.19.

What is the current dividend yield for Indoco Remedies Ltd.?

As of 6 June 2025, the dividend yield for Indoco Remedies Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Indoco Remedies Ltd.?

Significant shareholdings in Indoco Remedies Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Indoco Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Indoco Remedies Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Indoco Remedies Ltd.?

Indoco Remedies Ltd. last declared a FINAL dividend of ₹ 0.2 per share for the financial period ending 2025. The record date was set as 2025-09-04, and the payment was/is scheduled around 2025-09-04. For the most current dividend announcements, refer to official company filings.